Olivier Mathieu/LinkedIn
Jul 9, 2026, 13:16
Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
Olivier Mathieu, Manager at Stago, shared a post on LinkedIn:
”Tomorrow’s routine assays were yesterday’s crazy ideas.
At isth2026, our Prospective Research Department team will be pleased to share concepts of new assays at the Stago scientific lounge.
Honored to showcase the work of an outstanding multidisciplinary team pushing innovation from early scientific ideas to future clinical applications to the benefit for patients.
Looking forward to engaging with the scientific community and bridging innovation with real-world needs in hemostasis.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT